1-3 of 3
Carmen Burgaleta, MD, PhD
Close
Sort by
Journal Articles

Newly acquired chromosome Abnormalities During Course of CLL: a Retrospective Collection Data From 2 Spanish Centers.

Javier Loscertales, MD, Eva Arranz, PhD, Maria-Angeles Sanz, PhD, Carmen Burgaleta, MD, PhD, Juan-José Gil-Fernández, MD, PhD, Juan Luis Steegmann, MD, PhD, Adrian Alegre, MD
Journal: Blood
Blood (2009) 114 (22): 4384.
https://doi.org/10.1182/blood.V114.22.4384.4384
Published: 2009
Journal Articles

Hypophosphatemia During Imatinib Treatment of Newly Diagnosed Chronic Myeloid Leukemia Patients Is Associated with Better Response.

Luis Felipe Casado, MD, PhD, Isabel Massague, MD, Pilar Giraldo, MD, Manuel Pérez-Encinas, MD, Raquel de Paz, MD, PhD, Joaquin Martínez-López, MD, PhD, Rafael Fores, MD, Santiago Osorio, MD, Maria José Requena, MD, Luis Palomera, MD, María Jesus Peñarrubia, MD, Carmen Burgaleta, MD, PhD, Begoña Maestro, PhD, Juan Luis Steegmann, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1121.
https://doi.org/10.1182/blood.V114.22.1121.1121
Published: 2009
Journal Articles

Response Predictive Factors to Anagrelide in Essential Thrombocythemia Diagnosed Patients.

Carlos Besses, MD, PhD, Manuel Giralt, MD, PhD, Luis Hernandez-Nieto, MD, PhD, Carmen Burgaleta, MD, PhD, Victor Navas, MD, PhD, Gema Ramirez, MD, PhD, Vicente Vicente, MD, PhD, Felix Carbonell, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4649.
https://doi.org/10.1182/blood.V110.11.4649.4649
Published: 2007